Antibiotic Classes and Activity |
|
|
|
|
|
|
|
Go to Comparison of
Antifungals |
|
Return to Main Index |
|
Bacteria by classification |
Gram Postive |
Gram Negative |
Anaerobes |
Atypical |
Other |
|
Cocci: Staphylcocci (clusters), S. pneumoniae (pairs), Group and
viridans streptococci (chains), Enterococcus sp (pairs and chains); Bacilli: Bacillus sp, Corynebacterium sp, Listeria monocytogenes,
Nocardia sp |
Cocci:
Moraxella catarrhalis, Neisseria gonorrhoeae, Neisseria meningitidis,
Haemophilus influenzae Bacilli: E. coli, Enterobacter sp, Citrobacter, Klebsiella sp, Proteus
sp, Serratia, Salmonella, Shigella, Acinetobacter, Helicobacter, Pseudomonas
aeruginosa |
Above diaphragm:
Peptococcus sp, Peptostreptoccus sp, Prevotella, Veillonella,
Actinomyces Below diaphragm: Clostridium
perfringens, tetani, & difficile, Bacteroides fragilis, disastonis,
ovatus, & thetaiotamicron, Fusobacterium |
Legionella pneumophilia,
Mycoplasma pneumoniae or hominis, Chlamydia pneumoniae or trachomatis |
Treponema pallidium (syphillis),
Borrelia burgdorferi (Lyme) |
|
|
|
|
|
|
|
|
|
|
|
Bacteria by infection site |
Mouth |
Skin/Soft Tissue |
Bone and Joint |
Abdomen |
Urinary Tract |
Upper Respiratory |
Lower Respiratory |
Meningitis |
|
Peptococcus,
Peptostreptococcus, Actinomyces |
S. aureus, S. pyogenes, S.
epidermidis, Pasteurella |
S. aureus, S. epidermidis,
Steptococci, N. gonorrhoeae, Gram-negative rods |
E. coli, Proteus, Klebsiella,
Enterococcus, Bacteroides sp |
E. coli, Proteus, Klebsiella,
Enterococcus, Staph saprophyticus |
|
Community: S.
pneumoniae, H. influenzae, K. pneumoniae, Legionella pneumophilia,
Mycoplasma, Chlamydia Hospital: K. pneumoniae, P. aeruginosa,
Enterobacter sp, Serratia sp, S. aureus |
S. pneumoniae, N. meningitis, H.
influenzae, Group B streptococcus, E. coli, Listeria |
|
|
|
|
|
|
|
|
|
|
Common Pathogens by
Disease |
|
|
|
Activity |
Antibiotic Class |
Drugs in Class |
Mechanism of Action |
Gram Positive |
Gram Negative |
Anaerobes |
Atypical |
Other |
Penicillins |
Penicillin G, Penicillin VK |
Inhibits cell wall synthesis by
binding to penicillin-binding proteins (PBP) which are located in bacterial
cell walls Are bactericidal (except
against enterococcus). |
Penicillin-susceptible S. Aureus
& S. Pneumoniae, Group streptococci, viridans, streptococci, enterococcus |
Neisseria sp. |
Above diaphragm sp (see above),
Clostridium sp |
None |
Treponema pallidum (syphilis) |
Penicillinase-Resistant
Penicillins |
Nafcillin, Oxacillin, Methicillin |
Same as above, except these were
designed to overcome the penicillinase enzyme of S. aureus which inactivated
natural penicillins |
Methicillin-susceptable S. aureus,
Group streptococci, Viridans streptococci |
None |
None |
None |
None |
Aminopenicillins |
Ampicillin, Amoxicillin |
Same as above. Developed to have increased activity
against gram-negative aerobes |
Penicillin-susceptible S. Aureus,
Group streptococci, viridans streptococci, Enterococcus sp, Listeria
monocytogenes |
Proteus mirabilis, Salmonella,
Shigella, some E. coli, some H. influenzae |
None |
None |
None |
Carboxypenicillins |
Carbenicillin, Ticarcillin |
Same as above. Have increased activity against resistant
gram-negative aerobes than Aminopenicillins |
Marginal activity |
Proteus mirabilis, Salmonella,
Shigella, some E. coli, some H. influenzae, Enterobacter sp, Pseudomonas
aeruginosa |
None |
None |
None |
Ureidopenicillins |
Piperacillin, Azlocillin |
Same as above. Have greater activity against resistant
gram-negative aerobes than Carboxypenicillins |
Viridans strep., Group strep, some
Enterococcus |
Proteus mirabilis, Salmonella,
Shigella, E. coli, some H. influenzae, Enterobacter sp, Pseudomonas
aeruginosa, Serratia marcescens, some Klebsiella sp |
Fairly good activity |
|
|
B-Lactamase
Inhibitor Combinations |
Unasyn, Augmentin, Timentin,
Zosyn |
Same as above. Have greater activity against B-lactamase
producing organisms |
S. aureus |
H. influenzae, E. coli, Proteus
sp, Klebsiella sp, Neisseria gonorrhoeae, Moraxella catarrhalis |
Bacteroides sp |
|
|
First
generation cephalosporins |
Duricef, Kefzol, Keflex,
Cephalothin, Velosef |
Inhibits cell wall synthesis by
binding to penicillin-binding proteins (PBP) which are located in bacterial
cell walls Best activity of
cephalosporins against gram-positive/limited against gram-negative. Are bactericidal. |
Methicillin-susceptable S. aureus,
Penicillin-susceptable S. pneumoniae, Group streptococci, Viridans
streptococci |
E. coli, K. pneumoniae, P.
mirabilis |
|
|
|
Second
generation cephalosporins |
Ceclor, Mandol, Zefazone, Precef,
Cefotan, Mefoxin, Cefzil, Ceftin, Zinacef, Lorabid |
Same as above. Slightly less active against
gram-positive, but more active against gram-negative and some anaerobic
activity. Are bactericidal. |
Methicillin-susceptable S. aureus,
Penicillin-susceptable S. pneumoniae, Group streptococci, Viridans
streptococci |
E. coli, K. pneumoniae, P.
mirabilis, H. influenzae, M. catarrhalis, Neisseria sp |
Bacteroides fragilis, Bacteroides
fragilis group - only with cefotan, mefoxin, & zefazone |
|
|
Third
generation cephalosporins |
Omnicef, Suprax, Claforan,
Vantin, Cefizox, Rocephin, Fortaz |
Same as above. Less active than
second generation against gram-positive, but more active against
gram-negative. Rocephin & Claforan have best activity against
gram-positive (including pen-resistant S. pneumoniae). Are bactericidal. |
|
E. coli, K. pneumoniae, P.
mirabilis, H. influenzae, M. catarrhalis, Neisseria gonorrhoeae (including
B-lactamase producing), N. meningitdis, Citrobacter sp, Enterobacter sp,
Acineobacter sp, Morganella morganii, Serratia marcescens, Providencia,
Pseudomonas aeruginosa (Fortaz) |
|
|
|
Fourth
generation cephalosporins |
Maxipime |
Same as above. Extended spectum of activity. Are bactericidal. |
Similar to Rochepin (see above) |
Similar to Fortaz (see above) |
|
|
|
Carbapenems |
Merrem, Primaxin, Invanz |
Inhibits cell wall synthesis by
binding to penicillin-binding proteins (PBP) which are located in bacterial
cell walls. Are bactericidal. |
Good coverage; does not cover
MRSA, VRE, coagulase-negative staph, or Nocardia |
Good coverage; does not cover S.
maltophilia |
Good coverage; does not cover C.
difficile |
None |
None |
Monobactams |
Azactam |
Same as above, except these bind
preferentially to PBP-3 of gram negative aerobes. Are bactericidal. |
Little to no activity |
E. coli, K. pneumoniae, P.,
mirabilis, S. marcescens, H. influenzae, M. catarrhalis, Enterobacter,
Citrobacter, Providencia, Morganella, Salmonella, Shigella, Pseudomonas
aeruginosa |
Little to no activity |
None |
None |
Fluoroquinalones |
Olders agents: Noroxin,
Cipro Newer
agents: Levaquin, Tequin, Avelox, Trovan, Factive |
Inhibit bacterial topoisomerases
which are necessary for DNA synthesis.
Primary target for gram-positive bacteria is DNA gyrase, and primary
target for gram-negative bacteria is Topoisomerase IV. Concentration-dependant bactericidal
activity |
Older agents have poor
activity. Newer agents cover MSSA,
Strep pneumoniae (including PRSP), group and viridans steptococci (limited
activity), and Enterococci sp (limited activity) |
All have excellent activity
(cipro=levo>gati>moxi). Cover E. coli, Klebsiella sp, Enterobacter sp,
Proteus sp, Salmonella, Shigella, Serratia marcescens, and other
enterobacteriaceae; H. influenzae, M. catarrhalis, Neisseria sp, Pseudomonas
aeruginosa (significant resistance - cipro & levaquin have best activity) |
Only Trovan has activity against
Bacteroides sp |
All have excellent activity
against atypical including: Legionella pneumonia (drugs of choice), Chlamydia
sp, Mycoplasma sp, Ureoplasma urealyticum |
Mycobacterium tuberculosis,
Bacillus anthracis |
Macrolides |
Erythromycin, Zithromax, Biaxin |
Inhibits protein synthesis by
reversibly binding to the 50S ribosomal subunit. Suppression of RNA-dependent protein synthesis. Bacteriostatic activity |
(biaxin>e-mycin>zithro) MSSA, strep pneumoniae (only PSSP -
resistance developing), group and viridans steptococci, bacillus sp,
corynebacterium sp |
(zithro>biaxin>e-mycin) H. influenzae (not e-mycin), M.
catarrhalis, Neisseria sp. Do not
have any activity against any enterobacteriaceae |
Activity against Peptococcus sp,
Peptosteptococcus sp, Prevotella, Veillonella, Actinomyces |
All have excellent activity
against atypical including: Legionella pneumonia (drugs of choice), Chlamydia
sp, Mycoplasma sp, Ureoplasma urealyticum |
Mycobacterium avium complex (MAC -
only A and C), Treponema pallidum, Campylobacter, Borrelia, Bordetella,
Brucella, Pasteurella |
Aminoglycosides |
Gentamicin, Tobramycin, Amikacin,
Kantrex, Neomycin, Steptomycin |
Irreversibly bind to 30S
ribosomes, which disrupt the initiation of protein synthesis, decreases
overall protein synthesis, and produces misreading of mRNA. Are bactericidal |
most S. aureus and
coagulase-negative staph, viridans steptococci, enterococcus sp |
All but steptomycin: E. coli, K.
pneumoniae, Proteus sp, Acinetobacter, Citrobacter, Enterobacter sp,
Morganella, Providencia, Serratia, Salmonella, Shigella, Pseudomonas
aeruginosa (amik>tobra>gent) |
None |
Coverage with amikacin and
streptomycin |
Mycobacterium tuberculosis -
streptomycin |
Vancomycin |
Vancomycin |
Binds to D-alanyl-D-alanine
portion of cell wall precursors to inhibit synthesis and assembly of the
second stage of peptidoglycan polymers.
Are bactericidal (except for Enterococcus) |
MSSA, MRSA, coagulase-negative
staph, Strept pneumoniae (including PRSP), Viridans streptococcus, Group
streptococcus, Enterococcus sp, Corynebacterium, Bacillus, Listeria |
None |
Actinomyces, Clostridium sp
(including C. difficile), Peptococcus, Peptostreptococcus |
None |
None |
Streptogramins |
Synercid |
Each agent
(quinupristin/dalfopristin) acts on 50S ribosomal subunits to inhiit early
and late stages of protein synthesis.
It is bacteriostatic |
MSSA, MRSA, coagulase-negative
staph, Strept pneumoniae (including PRSP), Viridans streptococcus, Group
streptococcus, Enterococcus faecium (only), Corynebacterium, Bacillus,
Listeria |
Limited activity against Neisseria
sp, and Moraxella |
Actinomyces, Clostridium sp
(except C. difficile), Peptococcus, Peptostreptococcus |
Mycoplasma, Legionella |
None |
Oxazolidinones |
Zyvox |
Binds to the 50S ribosomal
subunit near to surface interface of 30S subunit, which causes inhibition of
70S initiation complex which inhibts protein synthesis. It is bacteriostatic |
MSSA, MRSA, VRSA,
coagulase-negative staph, strep pneumoniae (including PRSP), viridans
streptococcus, Group streptococcus, Enterococcus faecium and faecalis
(including VRE), Bacillus, Listeria |
Relatively inactive |
Clostridium sp (except C.
difficile), Peptostreptococcus, P. acnes |
Mycoplasma, Chlamydia, Legionella |
None |
Lincosamide |
Clindamycin, Lincocin |
Binds to 50S ribosomal subunit to
inhibit protein synthesis. Typically
is bacteriostatic. |
MSSA, Strep pneumoniae (PSSP
only), Group and viridans streptococci |
None |
Peptostreptococcus, some
Bacteroides sp, Actinomyces, Prevotella sp, Propionibacterium, Fusobacterium,
Clostridium sp (not C. difficile) |
None |
Pneumocystis carinii,
Toxoplasmosis gondii, Malaria |
Metronidazole |
Flagyl |
Prodrug which is activated by a
reductive process. It have selective
toxicity against anaerobic and microaerophilic bacteria due to the presence
of ferredoxins within these bacteria.
It it bactericidal. |
None |
None |
Bacteria: Bacteroides sp (all),
Fusobacterium, Prevotella sp, Clostridium sp (all), Helicobacter pylori;
Protozoa: Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia,
Gardnerella vaginalis |
None |
None |
Glycylcyclines |
Tygacil |
Reversibly binds to the A site of
the 30S ribosomal subunit. It is
bacteriostatic, but demonstrates bactericidal activity against certain
pathogens |
Enterococcus faecalis,
Enterococcus faecium (both VRE and non-VRE), Staph aureus (both MRSA and
MSSA), Streptococcus pneumoniae (both PCN susceptible and PCN resistant) |
Acinetobacter baumannii,
Enterobacter cloacae, Enterobacteriaceae sp, E. coli (both ESBL and
non-ESBL), H. influenzae (both BL positive and negative), K. pneumoniae (both
ESBL and non-ESBL), P. aueruginosa, S. marcescens |
Fusobacterium sp, Prevotella sp,
Peptostreptococcus sp, C. difficile |
None |
None |
Cyclic
Lipopeptide |
Cubicin |
Binds to components of the cell
membrane of susceptible organisms and causes rapid depolarization, inhibiting
intracellular synthesis of DNA, RNA, and protein. It is bactericidal in a concentration dependent manner |
MSSA, MRSA, coagulase negative
staphylococci, oxacillin-resistant S. aureus & S. epidermidis, PCN susp
& resistant S. pneumoniae, viridans steptococci, streptococcus sp, VSE,
VRE |
None |
None |
None |
None |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|